Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
With more than twenty years of experience in clinical medicine and research in endocrinology and obesity medicine, Dr. Sibley has conducted human clinical and translational research studies with a focus on obesity and metabolic syndrome in various populations. She completed her undergraduate and medical degrees at the University of Tennessee, her internship/residency training at Washington University-Barnes Hospital, and fellowships in nephrology and endocrinology, as well as an MPH/Epidemiology concentration, at the University of Washington. Her obesity-related research career began with a K23 involving central obesity and elevated albumin excretion in type 1 diabetes. Over the years her translational and clinical research experience has included smaller detailed patient-oriented studies of obesity-related physiology, both cross-sectional and under weight loss conditions, and collaboration in larger epidemiologic cohort studies including populations such as the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. Her prior patient-oriented research and clinical experiences have led her into work on appetitive control in collaboration with colleagues in behavioral health. She is studying the effects of neuromodulation as a tool for enhancing neuroplasticity and weight loss in individuals with obesity. Dr. Sibley is committed to finding innovative approaches for treatment of obesity and its comorbidities.